Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2009
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608450 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
10/27/2009US7608445 Increased activity and stability at increased pH and temperature
10/27/2009US7608437 Producing coryneform bacteria with an improved amino acid or nucleic acid productivity by introducing a mutation in a promoter sequence of biosynthesizing genes on a chromosome of a coryneform bacterium so that it is close to a consensus sequence; high yields; producing L-glutamic acid
10/27/2009US7608433 Multiplex real-time RT-PCR assay with a heterologous internal control system; could be performed as a one-tube assay without loss of sensitivity or specificity
10/27/2009US7608423 Expanding the eukaryotic genetic code
10/27/2009US7608419 Method and apparatus for detecting and quantifying bacterial spores on a surface
10/27/2009US7608418 NT-proANP and NT-proBNP for diagnosing cardiac diseases
10/27/2009US7608417 Cell electro-physiological sensor and method of manufacturing the same
10/27/2009US7608416 Targeting mPGES-1 as a treatment for inflammation which avoids cardiovascular risk
10/27/2009US7608415 Employing a genetically modified cell expressing one or more proteins of interest fused to a fragment that is a member of an enzyme fragment complementation ("EFC") pair; Western blotting; high sensitivity and the ability to observe modifications of the target protein
10/27/2009US7608410 Method of improving T cell receptors
10/27/2009US7608408 Methods of identifying compounds that inhibit Notch cleavage
10/27/2009US7608406 Diagnostic markers of stroke and cerebral injury and methods of use thereof
10/27/2009US7608403 Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell
10/27/2009US7608402 Rapidly detecting gene specific methylation through signal amplification using the epi-barcode after hybrid capture of the methylated DNA sequence
10/27/2009US7608401 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/27/2009US7608400 Methods for detecting a cyclophilin B SNP associated with HERDA
10/27/2009US7608399 Fluorescence method for determining the quantity of nucleic acids in a sample; provide results within a short amount of time in a closed sterile device that would allow for the clinical determination of the level of microbial contamination within a sample
10/27/2009US7608398 Minimally cross-hybridizing nucleotide sequences; provides of a family of molecules which is sufficiently large and where each individual member is sufficiently selective for its complement over all the other zipcode molecules
10/27/2009US7608397 Using variation in dielectric constant as tool in detecting change in conformational or energetic state of molecular species
10/27/2009US7608396 Systems, tools and methods of assaying biological materials using spatially-addressable arrays
10/27/2009US7608395 Predicts the likelihood of renal involvement, diagnose SLE, distinguish SLE gene expression profiles from profiles of patients infected with influenza, and to monitor disease progression and treatment
10/27/2009US7608394 Methods and compositions for phenotype identification based on nucleic acid methylation
10/27/2009US7608393 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
10/27/2009US7608392 Diagnostic assay for measuring a cell mediated immune response
10/27/2009US7608305 Methods for uniform metal impregnation into a nanoporous material
10/27/2009US7608263 RG1 antibodies and uses thereof
10/27/2009US7608255 Replication-competent anti-cancer vectors
10/27/2009US7608246 combination of apolipoprotein E and an antigenic lipid administered to a subject for the purpose of inducing an immune response against the lipid and in immunization protocols
10/27/2009US7608180 Determining concentration of hydrogen peroxide using organic quaternary ammonium or phosphonium ferricyanide compound which in reduced form functions as mediator specific to hydrogen peroxide; detected electrochemically at potential of -400 mV (Ag/AgCl) where oxidation of common interferants is avoided
10/27/2009US7608175 Electrochemical cell
10/27/2009CA2539510C Size-controlled macromolecule
10/27/2009CA2390867C Method for the production of biopolymers with modified properties
10/27/2009CA2372085C L-ribo-lna analogues
10/27/2009CA2349529C Pge synthase and methods and means for modulating its activity
10/27/2009CA2339323C Primer-specific and mispair extension assay for identifying gene variation
10/27/2009CA2327547C Oligonucleotides containing pyrazolo[3,4-d]pyrimidines for hybridization and mismatch discrimination
10/27/2009CA2230967C Improved nucleic acid assays
10/27/2009CA2224143C Recombinant hexose oxidase, a method of producing same and use of such enzyme
10/27/2009CA2202154C Methods for drug screening
10/22/2009WO2009129524A2 High-throughput plasmid dna preparation
10/22/2009WO2009129505A2 Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
10/22/2009WO2009129454A2 Predicting risk of major adverse cardiac events
10/22/2009WO2009129397A2 High throughput dispenser
10/22/2009WO2009129347A1 Improved direct antimicrobial susceptibility assay
10/22/2009WO2009129314A2 Downy mildew resistant cucumber plants
10/22/2009WO2009129236A2 Method for manipulating samples with magnetic nucleation nanoparticles
10/22/2009WO2009129154A1 Diagnostic methods for determining prognosis of non-small cell lung cancer
10/22/2009WO2009129108A1 Biosensor coating compositions and methods thereof
10/22/2009WO2009128978A1 Methods for detecting organisms and enzymatic reactions using raman spectroscopy
10/22/2009WO2009128960A2 Rapid test including genetic sequence probe
10/22/2009WO2009128953A2 Genetic variants in a hypertension susceptibility gene stk39 and uses thereof
10/22/2009WO2009128938A1 Hydrodynamic focusing for analyzing rectangular microbeads
10/22/2009WO2009128931A1 In vitro estimation of in vivo half-life binding proteins
10/22/2009WO2009128911A2 Genetics variants associated with hiv disease restriction
10/22/2009WO2009128734A1 Marker assisted identification of mammals for desired phenotypic trait
10/22/2009WO2009128730A1 Methods and compositions for the assessment of drug response
10/22/2009WO2009128714A1 Mal, a molecular diagnostic marker for hpv-induced invasive cancers and their high-grade precursor lesions
10/22/2009WO2009128644A2 Genome-scale butanol-producing microorganism metabolic network model and methods using the same for analysis of metabolic characteristics of butanol-producing microorganisms and for screening deletion targets
10/22/2009WO2009128526A1 Apparatus for the identification of ribonucleic acid, method for the identification of ribonucleic acid and program and system for the identification of ribonucleic acid
10/22/2009WO2009128483A1 Cell selection apparatus, and cell selection method using the same
10/22/2009WO2009128461A1 Method for quantification of γ-aminobutyric acid
10/22/2009WO2009128453A1 Proliferative disease detection method
10/22/2009WO2009128399A1 Oligonucleotide probe and microarray for determination of genome type of bk virus
10/22/2009WO2009128348A1 Phenylphosphorylcholine derivatives
10/22/2009WO2009127872A1 Reverse reporter assay
10/22/2009WO2009127855A1 Use of a monophosphate ester of a phthalein compound as a substrate for tartrate-resistant acid phosphatase b5 (trap 5b)
10/22/2009WO2009127751A1 Buffer for spotting a substrate in a solid medium
10/22/2009WO2009127644A1 Markers of acute kidney failure
10/22/2009WO2009127630A1 Fntb promoter polymorphisms
10/22/2009WO2009127408A1 Process for the quantitative determination of the copier number of a predetermined sequence in a sample
10/22/2009WO2009127211A1 Methods and kits for determining spinal dysmyelination
10/22/2009WO2009127154A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009WO2009127081A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009WO2009108866A3 Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof
10/22/2009WO2009108170A9 Compositions and methods for determining immune status
10/22/2009WO2009103494A3 Sgk1 as a therapeutic and diagnostic target for carcinomatous diseases
10/22/2009WO2009092597A3 Methods and nucleic acids for analyses of prostate cancer
10/22/2009WO2009091186A3 Health diagnosis system using bio-disc and method for diagnosing health using the same
10/22/2009WO2009088222A9 Method using genetic profiling of bioavailability or bioequivalence of xenobiotics
10/22/2009WO2009070767A3 Systemic instigation systems to study tumor growth or metastasis
10/22/2009WO2009058908A3 Methods for prognosing the ability of a zearalenone analog compound to treat cancer
10/22/2009WO2009052123A3 Multiplexed detection schemes for a droplet actuator
10/22/2009WO2009048873A4 Detection of atypical pneumonia
10/22/2009WO2009048673A3 Stochastic confinement to detect, manipulate, and utilize molecules and organisms
10/22/2009WO2009039136A3 Self-actuating signal producing detection devices and methods
10/22/2009WO2007025085A8 Genemap of the human genes associated with crohn's disease
10/22/2009WO2006050352A9 Blood test prototypes and methods for the detetion of circulating tumor and endothelial cells
10/22/2009WO2001000878A9 A novel vascular endothelial growth factor family member and uses thereof
10/22/2009US20090265817 Herbicide resistant transformed sugar beet that is detectable by the specific primers; glyphosate resistant sugar beet plant
10/22/2009US20090265816 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof
10/22/2009US20090265815 Sequence-determined DNA fragments and corresponding polypeptides encoded therapy
10/22/2009US20090265814 Plant transformation with in vivo assembly of a sequence of interest
10/22/2009US20090265805 Glutamate receptors in nutrient sensing, metabolism, Growth and Development
10/22/2009US20090265804 Nucleotide sequences encoding enzymes in biosynthesis of dihydroartemisinic acid
10/22/2009US20090265803 Downy mildew resistant cucumber plants
10/22/2009US20090265795 Methods of Inhibiting Multiple Cytochrome P450 Genes with siRNA
10/22/2009US20090265115 Method and apparatus for analyzing dna
10/22/2009US20090264779 Predicting risk of major adverse cardiac events
1 ... 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 ... 3003